nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—CYP2C9—Estropipate—osteoporosis	0.114	0.518	CbGbCtD
Treprostinil—CYP2C9—Cholecalciferol—osteoporosis	0.0586	0.267	CbGbCtD
Treprostinil—CYP2C9—Estradiol—osteoporosis	0.0473	0.215	CbGbCtD
Treprostinil—PPARD—NRF2 pathway—AGER—osteoporosis	0.00101	0.00419	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—MGLL—osteoporosis	0.000991	0.0041	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00099	0.0041	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ANXA2—osteoporosis	0.000985	0.00407	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PLEK—osteoporosis	0.000985	0.00407	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—IRS2—osteoporosis	0.000969	0.00401	CbGpPWpGaD
Treprostinil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000963	0.00398	CbGpPWpGaD
Treprostinil—CYP2C9—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.00095	0.00393	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—LEP—osteoporosis	0.000948	0.00392	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.000938	0.00388	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PLEK—osteoporosis	0.000906	0.00375	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ANXA2—osteoporosis	0.000906	0.00375	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CALCR—osteoporosis	0.000856	0.00354	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PTH1R—osteoporosis	0.000856	0.00354	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TLN1—osteoporosis	0.000849	0.00351	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—IRS1—osteoporosis	0.000846	0.0035	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—VCL—osteoporosis	0.000837	0.00346	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—PTH—osteoporosis	0.000796	0.00329	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000792	0.00328	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PTH1R—osteoporosis	0.000788	0.00326	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CALCR—osteoporosis	0.000788	0.00326	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—IGF1—osteoporosis	0.000783	0.00324	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TLN1—osteoporosis	0.000781	0.00323	CbGpPWpGaD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.00078	0.00323	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CALCR—osteoporosis	0.000778	0.00322	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PTH1R—osteoporosis	0.000778	0.00322	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CNR2—osteoporosis	0.000776	0.00321	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VCL—osteoporosis	0.000771	0.00319	CbGpPWpGaD
Treprostinil—PTGIR—G alpha (s) signalling events—POMC—osteoporosis	0.00077	0.00319	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—PTH—osteoporosis	0.000733	0.00303	CbGpPWpGaD
Treprostinil—Arthralgia—Pamidronate—osteoporosis	0.00073	0.00136	CcSEcCtD
Treprostinil—Myalgia—Pamidronate—osteoporosis	0.00073	0.00136	CcSEcCtD
Treprostinil—Back pain—Conjugated Estrogens—osteoporosis	0.00073	0.00136	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—WNT1—osteoporosis	0.000729	0.00302	CbGpPWpGaD
Treprostinil—Epistaxis—Estradiol—osteoporosis	0.000729	0.00135	CcSEcCtD
Treprostinil—Anxiety—Pamidronate—osteoporosis	0.000728	0.00135	CcSEcCtD
Treprostinil—Ill-defined disorder—Zoledronate—osteoporosis	0.000727	0.00135	CcSEcCtD
Treprostinil—Body temperature increased—Alendronate—osteoporosis	0.000726	0.00135	CcSEcCtD
Treprostinil—Abdominal pain—Alendronate—osteoporosis	0.000726	0.00135	CcSEcCtD
Treprostinil—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000725	0.00135	CcSEcCtD
Treprostinil—Sinusitis—Estradiol—osteoporosis	0.000725	0.00135	CcSEcCtD
Treprostinil—Shock—Risedronate—osteoporosis	0.000725	0.00135	CcSEcCtD
Treprostinil—Anaemia—Zoledronate—osteoporosis	0.000724	0.00134	CcSEcCtD
Treprostinil—Discomfort—Pamidronate—osteoporosis	0.000722	0.00134	CcSEcCtD
Treprostinil—Angioedema—Zoledronate—osteoporosis	0.000716	0.00133	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—PTH1R—osteoporosis	0.000716	0.00296	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CALCR—osteoporosis	0.000716	0.00296	CbGpPWpGaD
Treprostinil—Gastrointestinal pain—Calcitriol—osteoporosis	0.000715	0.00133	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CNR2—osteoporosis	0.000714	0.00295	CbGpPWpGaD
Treprostinil—Body temperature increased—Raloxifene—osteoporosis	0.000714	0.00133	CcSEcCtD
Treprostinil—Abdominal pain—Raloxifene—osteoporosis	0.000714	0.00133	CcSEcCtD
Treprostinil—Malaise—Zoledronate—osteoporosis	0.000707	0.00131	CcSEcCtD
Treprostinil—Body temperature increased—Ibandronate—osteoporosis	0.000707	0.00131	CcSEcCtD
Treprostinil—Abdominal pain—Ibandronate—osteoporosis	0.000707	0.00131	CcSEcCtD
Treprostinil—Syncope—Zoledronate—osteoporosis	0.000703	0.0013	CcSEcCtD
Treprostinil—Oedema—Pamidronate—osteoporosis	0.0007	0.0013	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—RAP1A—osteoporosis	0.0007	0.00289	CbGpPWpGaD
Treprostinil—Haemoglobin—Estradiol—osteoporosis	0.000697	0.00129	CcSEcCtD
Treprostinil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000696	0.00288	CbGpPWpGaD
Treprostinil—Infection—Pamidronate—osteoporosis	0.000696	0.00129	CcSEcCtD
Treprostinil—Rhinitis—Estradiol—osteoporosis	0.000696	0.00129	CcSEcCtD
Treprostinil—Haemorrhage—Estradiol—osteoporosis	0.000694	0.00129	CcSEcCtD
Treprostinil—Palpitations—Zoledronate—osteoporosis	0.000693	0.00129	CcSEcCtD
Treprostinil—Body temperature increased—Calcitriol—osteoporosis	0.000692	0.00128	CcSEcCtD
Treprostinil—Abdominal pain—Calcitriol—osteoporosis	0.000692	0.00128	CcSEcCtD
Treprostinil—Angioedema—Conjugated Estrogens—osteoporosis	0.000689	0.00128	CcSEcCtD
Treprostinil—Shock—Pamidronate—osteoporosis	0.000689	0.00128	CcSEcCtD
Treprostinil—Loss of consciousness—Zoledronate—osteoporosis	0.000689	0.00128	CcSEcCtD
Treprostinil—Pharyngitis—Estradiol—osteoporosis	0.000689	0.00128	CcSEcCtD
Treprostinil—Thrombocytopenia—Pamidronate—osteoporosis	0.000686	0.00127	CcSEcCtD
Treprostinil—Vomiting—Etidronic acid—osteoporosis	0.000685	0.00127	CcSEcCtD
Treprostinil—PPARD—Gene Expression—U2AF1—osteoporosis	0.000685	0.00283	CbGpPWpGaD
Treprostinil—Cough—Zoledronate—osteoporosis	0.000684	0.00127	CcSEcCtD
Treprostinil—Oedema peripheral—Estradiol—osteoporosis	0.000683	0.00127	CcSEcCtD
Treprostinil—Tachycardia—Pamidronate—osteoporosis	0.000683	0.00127	CcSEcCtD
Treprostinil—P2RY12—G alpha (i) signalling events—ADCY5—osteoporosis	0.000682	0.00282	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—MGLL—osteoporosis	0.00068	0.00281	CbGpPWpGaD
Treprostinil—Rash—Etidronic acid—osteoporosis	0.000679	0.00126	CcSEcCtD
Treprostinil—Dermatitis—Etidronic acid—osteoporosis	0.000679	0.00126	CcSEcCtD
Treprostinil—Syncope—Conjugated Estrogens—osteoporosis	0.000677	0.00126	CcSEcCtD
Treprostinil—Headache—Etidronic acid—osteoporosis	0.000675	0.00125	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000673	0.00279	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—WNT1—osteoporosis	0.000671	0.00278	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000671	0.00125	CcSEcCtD
Treprostinil—Asthenia—Estropipate—osteoporosis	0.000669	0.00124	CcSEcCtD
Treprostinil—Anorexia—Pamidronate—osteoporosis	0.000667	0.00124	CcSEcCtD
Treprostinil—Chest pain—Zoledronate—osteoporosis	0.000667	0.00124	CcSEcCtD
Treprostinil—Myalgia—Zoledronate—osteoporosis	0.000667	0.00124	CcSEcCtD
Treprostinil—Arthralgia—Zoledronate—osteoporosis	0.000667	0.00124	CcSEcCtD
Treprostinil—Palpitations—Conjugated Estrogens—osteoporosis	0.000667	0.00124	CcSEcCtD
Treprostinil—Insomnia—Risedronate—osteoporosis	0.000666	0.00124	CcSEcCtD
Treprostinil—Anxiety—Zoledronate—osteoporosis	0.000665	0.00123	CcSEcCtD
Treprostinil—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000663	0.00123	CcSEcCtD
Treprostinil—Paraesthesia—Risedronate—osteoporosis	0.000661	0.00123	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—PTHLH—osteoporosis	0.00066	0.00273	CbGpPWpGaD
Treprostinil—Pruritus—Estropipate—osteoporosis	0.000659	0.00122	CcSEcCtD
Treprostinil—Discomfort—Zoledronate—osteoporosis	0.000659	0.00122	CcSEcCtD
Treprostinil—Asthenia—Alendronate—osteoporosis	0.000659	0.00122	CcSEcCtD
Treprostinil—Cough—Conjugated Estrogens—osteoporosis	0.000658	0.00122	CcSEcCtD
Treprostinil—Dyspnoea—Risedronate—osteoporosis	0.000657	0.00122	CcSEcCtD
Treprostinil—Hypotension—Pamidronate—osteoporosis	0.000654	0.00121	CcSEcCtD
Treprostinil—Fatigue—Ethinyl Estradiol—osteoporosis	0.000651	0.00121	CcSEcCtD
Treprostinil—Pruritus—Alendronate—osteoporosis	0.000649	0.00121	CcSEcCtD
Treprostinil—Dyspepsia—Risedronate—osteoporosis	0.000648	0.0012	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—RAP1A—osteoporosis	0.000644	0.00266	CbGpPWpGaD
Treprostinil—Flushing—Estradiol—osteoporosis	0.000644	0.0012	CcSEcCtD
Treprostinil—Chest pain—Conjugated Estrogens—osteoporosis	0.000642	0.00119	CcSEcCtD
Treprostinil—Arthralgia—Conjugated Estrogens—osteoporosis	0.000642	0.00119	CcSEcCtD
Treprostinil—Myalgia—Conjugated Estrogens—osteoporosis	0.000642	0.00119	CcSEcCtD
Treprostinil—Asthenia—Ibandronate—osteoporosis	0.000641	0.00119	CcSEcCtD
Treprostinil—Anxiety—Conjugated Estrogens—osteoporosis	0.00064	0.00119	CcSEcCtD
Treprostinil—Nausea—Etidronic acid—osteoporosis	0.00064	0.00119	CcSEcCtD
Treprostinil—Oedema—Zoledronate—osteoporosis	0.00064	0.00119	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000638	0.00118	CcSEcCtD
Treprostinil—Diarrhoea—Estropipate—osteoporosis	0.000638	0.00118	CcSEcCtD
Treprostinil—Infection—Zoledronate—osteoporosis	0.000635	0.00118	CcSEcCtD
Treprostinil—Fatigue—Risedronate—osteoporosis	0.000635	0.00118	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—FGA—osteoporosis	0.000635	0.00263	CbGpPWpGaD
Treprostinil—Insomnia—Pamidronate—osteoporosis	0.000633	0.00118	CcSEcCtD
Treprostinil—Pruritus—Ibandronate—osteoporosis	0.000632	0.00117	CcSEcCtD
Treprostinil—Pain—Risedronate—osteoporosis	0.00063	0.00117	CcSEcCtD
Treprostinil—Shock—Zoledronate—osteoporosis	0.000629	0.00117	CcSEcCtD
Treprostinil—Paraesthesia—Pamidronate—osteoporosis	0.000629	0.00117	CcSEcCtD
Treprostinil—Diarrhoea—Alendronate—osteoporosis	0.000628	0.00117	CcSEcCtD
Treprostinil—Asthenia—Calcitriol—osteoporosis	0.000628	0.00117	CcSEcCtD
Treprostinil—Thrombocytopenia—Zoledronate—osteoporosis	0.000626	0.00116	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—MGLL—osteoporosis	0.000626	0.00259	CbGpPWpGaD
Treprostinil—Dyspnoea—Pamidronate—osteoporosis	0.000624	0.00116	CcSEcCtD
Treprostinil—Tachycardia—Zoledronate—osteoporosis	0.000624	0.00116	CcSEcCtD
Treprostinil—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000623	0.00116	CcSEcCtD
Treprostinil—Pruritus—Calcitriol—osteoporosis	0.000619	0.00115	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—MGLL—osteoporosis	0.000618	0.00256	CbGpPWpGaD
Treprostinil—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000618	0.00115	CcSEcCtD
Treprostinil—Diarrhoea—Raloxifene—osteoporosis	0.000618	0.00115	CcSEcCtD
Treprostinil—Dyspepsia—Pamidronate—osteoporosis	0.000616	0.00114	CcSEcCtD
Treprostinil—Dizziness—Estropipate—osteoporosis	0.000616	0.00114	CcSEcCtD
Treprostinil—Oedema—Conjugated Estrogens—osteoporosis	0.000616	0.00114	CcSEcCtD
Treprostinil—PPARD—Metabolism—FDPS—osteoporosis	0.000614	0.00254	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PKM—osteoporosis	0.000614	0.00254	CbGpPWpGaD
Treprostinil—Infection—Conjugated Estrogens—osteoporosis	0.000612	0.00114	CcSEcCtD
Treprostinil—Diarrhoea—Ibandronate—osteoporosis	0.000612	0.00114	CcSEcCtD
Treprostinil—Anorexia—Zoledronate—osteoporosis	0.00061	0.00113	CcSEcCtD
Treprostinil—Decreased appetite—Pamidronate—osteoporosis	0.000609	0.00113	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—PTHLH—osteoporosis	0.000607	0.00251	CbGpPWpGaD
Treprostinil—Dizziness—Alendronate—osteoporosis	0.000607	0.00113	CcSEcCtD
Treprostinil—Shock—Conjugated Estrogens—osteoporosis	0.000606	0.00112	CcSEcCtD
Treprostinil—Erythema—Estradiol—osteoporosis	0.000604	0.00112	CcSEcCtD
Treprostinil—Fatigue—Pamidronate—osteoporosis	0.000604	0.00112	CcSEcCtD
Treprostinil—Gastrointestinal pain—Risedronate—osteoporosis	0.000602	0.00112	CcSEcCtD
Treprostinil—Tachycardia—Conjugated Estrogens—osteoporosis	0.000601	0.00112	CcSEcCtD
Treprostinil—Pain—Pamidronate—osteoporosis	0.000599	0.00111	CcSEcCtD
Treprostinil—Diarrhoea—Calcitriol—osteoporosis	0.000599	0.00111	CcSEcCtD
Treprostinil—Hypotension—Zoledronate—osteoporosis	0.000598	0.00111	CcSEcCtD
Treprostinil—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000597	0.00111	CcSEcCtD
Treprostinil—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000597	0.00111	CcSEcCtD
Treprostinil—Dizziness—Raloxifene—osteoporosis	0.000597	0.00111	CcSEcCtD
Treprostinil—Tension—Estradiol—osteoporosis	0.000593	0.0011	CcSEcCtD
Treprostinil—Vomiting—Estropipate—osteoporosis	0.000593	0.0011	CcSEcCtD
Treprostinil—Dizziness—Ibandronate—osteoporosis	0.000591	0.0011	CcSEcCtD
Treprostinil—Rash—Estropipate—osteoporosis	0.000588	0.00109	CcSEcCtD
Treprostinil—Dermatitis—Estropipate—osteoporosis	0.000587	0.00109	CcSEcCtD
Treprostinil—Anorexia—Conjugated Estrogens—osteoporosis	0.000587	0.00109	CcSEcCtD
Treprostinil—Nervousness—Estradiol—osteoporosis	0.000587	0.00109	CcSEcCtD
Treprostinil—Back pain—Estradiol—osteoporosis	0.000584	0.00108	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—FGA—osteoporosis	0.000584	0.00242	CbGpPWpGaD
Treprostinil—Headache—Estropipate—osteoporosis	0.000584	0.00108	CcSEcCtD
Treprostinil—Vomiting—Alendronate—osteoporosis	0.000584	0.00108	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000583	0.00108	CcSEcCtD
Treprostinil—Abdominal pain—Risedronate—osteoporosis	0.000582	0.00108	CcSEcCtD
Treprostinil—Body temperature increased—Risedronate—osteoporosis	0.000582	0.00108	CcSEcCtD
Treprostinil—PPARD—Metabolism—PGLS—osteoporosis	0.000582	0.00241	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GPD2—osteoporosis	0.000582	0.00241	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CALCA—osteoporosis	0.000581	0.0024	CbGpPWpGaD
Treprostinil—Muscle spasms—Estradiol—osteoporosis	0.000581	0.00108	CcSEcCtD
Treprostinil—Rash—Alendronate—osteoporosis	0.000579	0.00107	CcSEcCtD
Treprostinil—Insomnia—Zoledronate—osteoporosis	0.000578	0.00107	CcSEcCtD
Treprostinil—Dermatitis—Alendronate—osteoporosis	0.000578	0.00107	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—FGB—osteoporosis	0.000577	0.00239	CbGpPWpGaD
Treprostinil—Feeling abnormal—Pamidronate—osteoporosis	0.000577	0.00107	CcSEcCtD
Treprostinil—Hypotension—Conjugated Estrogens—osteoporosis	0.000575	0.00107	CcSEcCtD
Treprostinil—Headache—Alendronate—osteoporosis	0.000575	0.00107	CcSEcCtD
Treprostinil—Paraesthesia—Zoledronate—osteoporosis	0.000574	0.00107	CcSEcCtD
Treprostinil—Vomiting—Raloxifene—osteoporosis	0.000574	0.00107	CcSEcCtD
Treprostinil—Gastrointestinal pain—Pamidronate—osteoporosis	0.000573	0.00106	CcSEcCtD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—MYC—osteoporosis	0.000572	0.00236	CbGpPWpGaD
Treprostinil—Dyspnoea—Zoledronate—osteoporosis	0.00057	0.00106	CcSEcCtD
Treprostinil—Rash—Raloxifene—osteoporosis	0.000569	0.00106	CcSEcCtD
Treprostinil—Dermatitis—Raloxifene—osteoporosis	0.000569	0.00106	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—MGLL—osteoporosis	0.000569	0.00235	CbGpPWpGaD
Treprostinil—Vomiting—Ibandronate—osteoporosis	0.000568	0.00106	CcSEcCtD
Treprostinil—Headache—Raloxifene—osteoporosis	0.000566	0.00105	CcSEcCtD
Treprostinil—Rash—Ibandronate—osteoporosis	0.000564	0.00105	CcSEcCtD
Treprostinil—Dermatitis—Ibandronate—osteoporosis	0.000563	0.00105	CcSEcCtD
Treprostinil—Dyspepsia—Zoledronate—osteoporosis	0.000563	0.00105	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000561	0.00104	CcSEcCtD
Treprostinil—Ill-defined disorder—Estradiol—osteoporosis	0.00056	0.00104	CcSEcCtD
Treprostinil—Headache—Ibandronate—osteoporosis	0.00056	0.00104	CcSEcCtD
Treprostinil—Insomnia—Conjugated Estrogens—osteoporosis	0.000557	0.00103	CcSEcCtD
Treprostinil—Vomiting—Calcitriol—osteoporosis	0.000556	0.00103	CcSEcCtD
Treprostinil—Decreased appetite—Zoledronate—osteoporosis	0.000556	0.00103	CcSEcCtD
Treprostinil—Nausea—Estropipate—osteoporosis	0.000554	0.00103	CcSEcCtD
Treprostinil—Body temperature increased—Pamidronate—osteoporosis	0.000554	0.00103	CcSEcCtD
Treprostinil—Abdominal pain—Pamidronate—osteoporosis	0.000554	0.00103	CcSEcCtD
Treprostinil—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000553	0.00103	CcSEcCtD
Treprostinil—Angioedema—Estradiol—osteoporosis	0.000552	0.00102	CcSEcCtD
Treprostinil—Rash—Calcitriol—osteoporosis	0.000552	0.00102	CcSEcCtD
Treprostinil—Fatigue—Zoledronate—osteoporosis	0.000551	0.00102	CcSEcCtD
Treprostinil—Dermatitis—Calcitriol—osteoporosis	0.000551	0.00102	CcSEcCtD
Treprostinil—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000549	0.00102	CcSEcCtD
Treprostinil—Headache—Calcitriol—osteoporosis	0.000548	0.00102	CcSEcCtD
Treprostinil—Pain—Zoledronate—osteoporosis	0.000547	0.00102	CcSEcCtD
Treprostinil—Nausea—Alendronate—osteoporosis	0.000545	0.00101	CcSEcCtD
Treprostinil—PPARD—Generic Transcription Pathway—ESR2—osteoporosis	0.000545	0.00225	CbGpPWpGaD
Treprostinil—Malaise—Estradiol—osteoporosis	0.000545	0.00101	CcSEcCtD
Treprostinil—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000542	0.00101	CcSEcCtD
Treprostinil—Asthenia—Ethinyl Estradiol—osteoporosis	0.000542	0.00101	CcSEcCtD
Treprostinil—Syncope—Estradiol—osteoporosis	0.000542	0.00101	CcSEcCtD
Treprostinil—Nausea—Raloxifene—osteoporosis	0.000536	0.000996	CcSEcCtD
Treprostinil—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000535	0.000994	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CALCA—osteoporosis	0.000534	0.00221	CbGpPWpGaD
Treprostinil—Pruritus—Ethinyl Estradiol—osteoporosis	0.000534	0.000992	CcSEcCtD
Treprostinil—Palpitations—Estradiol—osteoporosis	0.000534	0.000991	CcSEcCtD
Treprostinil—PPARD—Metabolism—PNP—osteoporosis	0.000532	0.0022	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ATIC—osteoporosis	0.000532	0.0022	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—FGB—osteoporosis	0.000531	0.0022	CbGpPWpGaD
Treprostinil—Fatigue—Conjugated Estrogens—osteoporosis	0.000531	0.000986	CcSEcCtD
Treprostinil—Nausea—Ibandronate—osteoporosis	0.000531	0.000986	CcSEcCtD
Treprostinil—Loss of consciousness—Estradiol—osteoporosis	0.000531	0.000986	CcSEcCtD
Treprostinil—Asthenia—Risedronate—osteoporosis	0.000528	0.000981	CcSEcCtD
Treprostinil—Feeling abnormal—Zoledronate—osteoporosis	0.000527	0.000979	CcSEcCtD
Treprostinil—Cough—Estradiol—osteoporosis	0.000527	0.000978	CcSEcCtD
Treprostinil—Pain—Conjugated Estrogens—osteoporosis	0.000527	0.000978	CcSEcCtD
Treprostinil—Gastrointestinal pain—Zoledronate—osteoporosis	0.000523	0.000971	CcSEcCtD
Treprostinil—Pruritus—Risedronate—osteoporosis	0.000521	0.000968	CcSEcCtD
Treprostinil—Nausea—Calcitriol—osteoporosis	0.00052	0.000965	CcSEcCtD
Treprostinil—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000517	0.00096	CcSEcCtD
Treprostinil—Myalgia—Estradiol—osteoporosis	0.000514	0.000955	CcSEcCtD
Treprostinil—Chest pain—Estradiol—osteoporosis	0.000514	0.000955	CcSEcCtD
Treprostinil—Arthralgia—Estradiol—osteoporosis	0.000514	0.000955	CcSEcCtD
Treprostinil—Anxiety—Estradiol—osteoporosis	0.000512	0.000951	CcSEcCtD
Treprostinil—PPARD—Gene Expression—RPL24—osteoporosis	0.000509	0.0021	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SOST—osteoporosis	0.000508	0.0021	CbGpPWpGaD
Treprostinil—Discomfort—Estradiol—osteoporosis	0.000508	0.000943	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000507	0.0021	CbGpPWpGaD
Treprostinil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000506	0.00209	CbGpPWpGaD
Treprostinil—Abdominal pain—Zoledronate—osteoporosis	0.000506	0.000939	CcSEcCtD
Treprostinil—Body temperature increased—Zoledronate—osteoporosis	0.000506	0.000939	CcSEcCtD
Treprostinil—Diarrhoea—Risedronate—osteoporosis	0.000504	0.000936	CcSEcCtD
Treprostinil—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000504	0.000935	CcSEcCtD
Treprostinil—Asthenia—Pamidronate—osteoporosis	0.000502	0.000933	CcSEcCtD
Treprostinil—P2RY12—G alpha (i) signalling events—POMC—osteoporosis	0.000502	0.00208	CbGpPWpGaD
Treprostinil—Dizziness—Ethinyl Estradiol—osteoporosis	0.0005	0.000928	CcSEcCtD
Treprostinil—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000499	0.00206	CbGpPWpGaD
Treprostinil—Pruritus—Pamidronate—osteoporosis	0.000495	0.00092	CcSEcCtD
Treprostinil—Oedema—Estradiol—osteoporosis	0.000493	0.000915	CcSEcCtD
Treprostinil—Infection—Estradiol—osteoporosis	0.00049	0.000909	CcSEcCtD
Treprostinil—Dizziness—Risedronate—osteoporosis	0.000487	0.000904	CcSEcCtD
Treprostinil—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000487	0.000904	CcSEcCtD
Treprostinil—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000487	0.000904	CcSEcCtD
Treprostinil—Shock—Estradiol—osteoporosis	0.000485	0.0009	CcSEcCtD
Treprostinil—Tachycardia—Estradiol—osteoporosis	0.000481	0.000893	CcSEcCtD
Treprostinil—Vomiting—Ethinyl Estradiol—osteoporosis	0.00048	0.000892	CcSEcCtD
Treprostinil—Diarrhoea—Pamidronate—osteoporosis	0.000479	0.00089	CcSEcCtD
Treprostinil—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	0.000476	0.00197	CbGpPWpGaD
Treprostinil—Rash—Ethinyl Estradiol—osteoporosis	0.000476	0.000884	CcSEcCtD
Treprostinil—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000476	0.000884	CcSEcCtD
Treprostinil—Headache—Ethinyl Estradiol—osteoporosis	0.000473	0.000879	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—TGFB1—osteoporosis	0.00047	0.00194	CbGpPWpGaD
Treprostinil—Vomiting—Risedronate—osteoporosis	0.000468	0.00087	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—SOST—osteoporosis	0.000468	0.00193	CbGpPWpGaD
Treprostinil—Rash—Risedronate—osteoporosis	0.000464	0.000862	CcSEcCtD
Treprostinil—Dermatitis—Risedronate—osteoporosis	0.000464	0.000862	CcSEcCtD
Treprostinil—Dizziness—Pamidronate—osteoporosis	0.000463	0.00086	CcSEcCtD
Treprostinil—Headache—Risedronate—osteoporosis	0.000461	0.000857	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—CALCR—osteoporosis	0.000459	0.0019	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTH1R—osteoporosis	0.000459	0.0019	CbGpPWpGaD
Treprostinil—Asthenia—Zoledronate—osteoporosis	0.000459	0.000852	CcSEcCtD
Treprostinil—PPARD—Metabolism—CA2—osteoporosis	0.000453	0.00187	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—OXCT1—osteoporosis	0.000453	0.00187	CbGpPWpGaD
Treprostinil—Pruritus—Zoledronate—osteoporosis	0.000452	0.00084	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—PTH—osteoporosis	0.00045	0.00186	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000449	0.000834	CcSEcCtD
Treprostinil—PPARD—Ectoderm Differentiation—MYC—osteoporosis	0.000449	0.00186	CbGpPWpGaD
Treprostinil—Nausea—Ethinyl Estradiol—osteoporosis	0.000449	0.000833	CcSEcCtD
Treprostinil—Insomnia—Estradiol—osteoporosis	0.000446	0.000828	CcSEcCtD
Treprostinil—Vomiting—Pamidronate—osteoporosis	0.000445	0.000827	CcSEcCtD
Treprostinil—Paraesthesia—Estradiol—osteoporosis	0.000443	0.000822	CcSEcCtD
Treprostinil—Asthenia—Conjugated Estrogens—osteoporosis	0.000442	0.00082	CcSEcCtD
Treprostinil—Rash—Pamidronate—osteoporosis	0.000441	0.00082	CcSEcCtD
Treprostinil—PPARD—Metabolism—MGLL—osteoporosis	0.000441	0.00182	CbGpPWpGaD
Treprostinil—Dermatitis—Pamidronate—osteoporosis	0.000441	0.000819	CcSEcCtD
Treprostinil—Dyspnoea—Estradiol—osteoporosis	0.000439	0.000816	CcSEcCtD
Treprostinil—Headache—Pamidronate—osteoporosis	0.000439	0.000814	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—TNF—osteoporosis	0.000438	0.00181	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CNR2—osteoporosis	0.000438	0.00181	CbGpPWpGaD
Treprostinil—Diarrhoea—Zoledronate—osteoporosis	0.000438	0.000813	CcSEcCtD
Treprostinil—Nausea—Risedronate—osteoporosis	0.000438	0.000812	CcSEcCtD
Treprostinil—Pruritus—Conjugated Estrogens—osteoporosis	0.000436	0.000809	CcSEcCtD
Treprostinil—Dyspepsia—Estradiol—osteoporosis	0.000434	0.000806	CcSEcCtD
Treprostinil—PPARD—Generic Transcription Pathway—VDR—osteoporosis	0.000432	0.00179	CbGpPWpGaD
Treprostinil—Decreased appetite—Estradiol—osteoporosis	0.000428	0.000796	CcSEcCtD
Treprostinil—PPARD—NRF2 pathway—TGFB1—osteoporosis	0.000428	0.00177	CbGpPWpGaD
Treprostinil—Fatigue—Estradiol—osteoporosis	0.000425	0.000789	CcSEcCtD
Treprostinil—Dizziness—Zoledronate—osteoporosis	0.000423	0.000785	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—PTH1R—osteoporosis	0.000423	0.00175	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CALCR—osteoporosis	0.000423	0.00175	CbGpPWpGaD
Treprostinil—Pain—Estradiol—osteoporosis	0.000421	0.000783	CcSEcCtD
Treprostinil—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000421	0.000782	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000416	0.00172	CbGpPWpGaD
Treprostinil—Nausea—Pamidronate—osteoporosis	0.000416	0.000772	CcSEcCtD
Treprostinil—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	0.000415	0.00172	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PTH—osteoporosis	0.000414	0.00171	CbGpPWpGaD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.00041	0.0017	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	0.000409	0.00169	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PTH—osteoporosis	0.000409	0.00169	CbGpPWpGaD
Treprostinil—Dizziness—Conjugated Estrogens—osteoporosis	0.000407	0.000756	CcSEcCtD
Treprostinil—Vomiting—Zoledronate—osteoporosis	0.000407	0.000755	CcSEcCtD
Treprostinil—Feeling abnormal—Estradiol—osteoporosis	0.000406	0.000754	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—CNR2—osteoporosis	0.000404	0.00167	CbGpPWpGaD
Treprostinil—Rash—Zoledronate—osteoporosis	0.000403	0.000749	CcSEcCtD
Treprostinil—Gastrointestinal pain—Estradiol—osteoporosis	0.000403	0.000748	CcSEcCtD
Treprostinil—Dermatitis—Zoledronate—osteoporosis	0.000403	0.000748	CcSEcCtD
Treprostinil—Headache—Zoledronate—osteoporosis	0.000401	0.000744	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000399	0.00165	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CNR2—osteoporosis	0.000398	0.00165	CbGpPWpGaD
Treprostinil—Vomiting—Conjugated Estrogens—osteoporosis	0.000392	0.000727	CcSEcCtD
Treprostinil—Body temperature increased—Estradiol—osteoporosis	0.00039	0.000723	CcSEcCtD
Treprostinil—Abdominal pain—Estradiol—osteoporosis	0.00039	0.000723	CcSEcCtD
Treprostinil—Rash—Conjugated Estrogens—osteoporosis	0.000388	0.000721	CcSEcCtD
Treprostinil—Dermatitis—Conjugated Estrogens—osteoporosis	0.000388	0.00072	CcSEcCtD
Treprostinil—Headache—Conjugated Estrogens—osteoporosis	0.000386	0.000716	CcSEcCtD
Treprostinil—Nausea—Zoledronate—osteoporosis	0.00038	0.000705	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—PTH—osteoporosis	0.000376	0.00156	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—IDH2—osteoporosis	0.000375	0.00155	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—WNT1—osteoporosis	0.000374	0.00155	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PTHLH—osteoporosis	0.000373	0.00154	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000367	0.00152	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CNR2—osteoporosis	0.000366	0.00152	CbGpPWpGaD
Treprostinil—Nausea—Conjugated Estrogens—osteoporosis	0.000366	0.000679	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—MGLL—osteoporosis	0.000365	0.00151	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LRP5—osteoporosis	0.000356	0.00147	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—IL6—osteoporosis	0.000354	0.00146	CbGpPWpGaD
Treprostinil—Asthenia—Estradiol—osteoporosis	0.000354	0.000657	CcSEcCtD
Treprostinil—PPARD—Metabolism—CYP27A1—osteoporosis	0.000353	0.00146	CbGpPWpGaD
Treprostinil—Pruritus—Estradiol—osteoporosis	0.000349	0.000647	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—WNT1—osteoporosis	0.000345	0.00143	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PTHLH—osteoporosis	0.000343	0.00142	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ACP5—osteoporosis	0.000343	0.00142	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LRP6—osteoporosis	0.000341	0.00141	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000339	0.0014	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PTHLH—osteoporosis	0.000339	0.0014	CbGpPWpGaD
Treprostinil—Diarrhoea—Estradiol—osteoporosis	0.000337	0.000626	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—MGLL—osteoporosis	0.000336	0.00139	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—ESR1—osteoporosis	0.00033	0.00137	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CALCA—osteoporosis	0.000328	0.00136	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LRP5—osteoporosis	0.000328	0.00136	CbGpPWpGaD
Treprostinil—Dizziness—Estradiol—osteoporosis	0.000326	0.000605	CcSEcCtD
Treprostinil—PPARD—Metabolism—TPI1—osteoporosis	0.000319	0.00132	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LRP6—osteoporosis	0.000314	0.0013	CbGpPWpGaD
Treprostinil—Vomiting—Estradiol—osteoporosis	0.000313	0.000582	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—PTHLH—osteoporosis	0.000312	0.00129	CbGpPWpGaD
Treprostinil—Rash—Estradiol—osteoporosis	0.000311	0.000577	CcSEcCtD
Treprostinil—Dermatitis—Estradiol—osteoporosis	0.00031	0.000576	CcSEcCtD
Treprostinil—Headache—Estradiol—osteoporosis	0.000309	0.000573	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000304	0.00126	CbGpPWpGaD
Treprostinil—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000304	0.00126	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—POMC—osteoporosis	0.000304	0.00126	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CALCA—osteoporosis	0.000302	0.00125	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—P4HB—osteoporosis	0.0003	0.00124	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CALCA—osteoporosis	0.000298	0.00123	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GAPDH—osteoporosis	0.000294	0.00122	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PSMA2—osteoporosis	0.000294	0.00121	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PSMA5—osteoporosis	0.000294	0.00121	CbGpPWpGaD
Treprostinil—Nausea—Estradiol—osteoporosis	0.000293	0.000544	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—TLN1—osteoporosis	0.000288	0.00119	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—RAP1A—osteoporosis	0.000287	0.00119	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—POMC—osteoporosis	0.00028	0.00116	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000277	0.00115	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CALCA—osteoporosis	0.000274	0.00113	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TLN1—osteoporosis	0.000265	0.0011	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000263	0.00109	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—ESR2—osteoporosis	0.000262	0.00109	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—IGF1—osteoporosis	0.000261	0.00108	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.00025	0.00103	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—P4HB—osteoporosis	0.000248	0.00103	CbGpPWpGaD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000246	0.00102	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTH—osteoporosis	0.000241	0.000999	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—IGF1—osteoporosis	0.000241	0.000995	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RAP1A—osteoporosis	0.000237	0.000981	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CNR2—osteoporosis	0.000235	0.000973	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—ADCY5—osteoporosis	0.000233	0.000966	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ENO1—osteoporosis	0.000232	0.000959	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NFATC1—osteoporosis	0.000231	0.000957	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—DKK1—osteoporosis	0.00023	0.00095	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—P4HB—osteoporosis	0.000228	0.000945	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PSMA5—osteoporosis	0.000228	0.000945	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PSMA2—osteoporosis	0.000228	0.000945	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTH—osteoporosis	0.000222	0.000919	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—WNT1—osteoporosis	0.000221	0.000915	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RAP1A—osteoporosis	0.000218	0.000903	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	0.000218	0.000901	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CNR2—osteoporosis	0.000216	0.000896	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FGA—osteoporosis	0.000215	0.00089	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—ADCY5—osteoporosis	0.000215	0.000889	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	0.000215	0.000889	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NFATC1—osteoporosis	0.000213	0.000881	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—ADCY5—osteoporosis	0.000212	0.000877	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—DKK1—osteoporosis	0.000211	0.000874	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—VDR—osteoporosis	0.000208	0.000861	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000204	0.000845	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—WNT1—osteoporosis	0.000204	0.000842	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTHLH—osteoporosis	0.0002	0.000827	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—BMP2—osteoporosis	0.0002	0.000827	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000199	0.000824	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FGA—osteoporosis	0.000198	0.000819	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FGB—osteoporosis	0.000196	0.00081	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—ADCY5—osteoporosis	0.000195	0.000807	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PSMA2—osteoporosis	0.000189	0.000782	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PSMA5—osteoporosis	0.000189	0.000782	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP19A1—osteoporosis	0.000185	0.000766	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTHLH—osteoporosis	0.000184	0.000761	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—BMP2—osteoporosis	0.000184	0.000761	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FGB—osteoporosis	0.00018	0.000745	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CALCA—osteoporosis	0.000176	0.000728	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PSMA2—osteoporosis	0.000174	0.000719	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PSMA5—osteoporosis	0.000174	0.000719	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—MYC—osteoporosis	0.000172	0.000711	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—POMC—osteoporosis	0.000172	0.00071	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CALCA—osteoporosis	0.000162	0.00067	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KL—osteoporosis	0.00016	0.000661	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000159	0.000659	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—ESR1—osteoporosis	0.000159	0.000658	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—POMC—osteoporosis	0.000158	0.000654	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TGFB1—osteoporosis	0.000157	0.000648	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—POMC—osteoporosis	0.000156	0.000645	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6R—osteoporosis	0.000152	0.000629	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ADCY5—osteoporosis	0.000151	0.000626	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GPX1—osteoporosis	0.000151	0.000624	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KL—osteoporosis	0.000147	0.000609	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TGFB1—osteoporosis	0.000144	0.000597	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—POMC—osteoporosis	0.000144	0.000594	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6R—osteoporosis	0.00014	0.000579	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—MTHFR—osteoporosis	0.000139	0.000576	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000135	0.00056	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—POMC—osteoporosis	0.000131	0.000541	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADCY5—osteoporosis	0.000125	0.000518	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—FDPS—osteoporosis	0.000123	0.000511	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PKM—osteoporosis	0.000123	0.000511	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SPP1—osteoporosis	0.000121	0.000501	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GPD2—osteoporosis	0.000117	0.000484	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PGLS—osteoporosis	0.000117	0.000484	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADCY5—osteoporosis	0.000115	0.000477	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SPP1—osteoporosis	0.000112	0.000461	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—POMC—osteoporosis	0.000111	0.000461	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IRS2—osteoporosis	0.00011	0.000453	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LEP—osteoporosis	0.000107	0.000444	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ATIC—osteoporosis	0.000107	0.000443	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PNP—osteoporosis	0.000107	0.000443	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ESR1—osteoporosis	0.000102	0.000424	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IRS2—osteoporosis	0.000101	0.000417	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LEP—osteoporosis	9.87e-05	0.000408	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IRS1—osteoporosis	9.57e-05	0.000396	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ESR1—osteoporosis	9.42e-05	0.00039	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—POMC—osteoporosis	9.21e-05	0.000381	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—OXCT1—osteoporosis	9.1e-05	0.000377	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CA2—osteoporosis	9.1e-05	0.000377	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6R—osteoporosis	8.99e-05	0.000372	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MGLL—osteoporosis	8.87e-05	0.000367	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF1—osteoporosis	8.86e-05	0.000367	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IRS1—osteoporosis	8.8e-05	0.000364	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—POMC—osteoporosis	8.48e-05	0.000351	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.36e-05	0.000346	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MYC—osteoporosis	8.28e-05	0.000342	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6R—osteoporosis	8.27e-05	0.000342	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF1—osteoporosis	8.15e-05	0.000337	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—IDH2—osteoporosis	7.54e-05	0.000312	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP27A1—osteoporosis	7.09e-05	0.000293	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ACP5—osteoporosis	6.9e-05	0.000285	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.81e-05	0.000282	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—osteoporosis	6.78e-05	0.00028	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TPI1—osteoporosis	6.41e-05	0.000265	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—osteoporosis	6.24e-05	0.000258	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—P4HB—osteoporosis	6.03e-05	0.000249	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GAPDH—osteoporosis	5.92e-05	0.000245	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—RAP1A—osteoporosis	5.76e-05	0.000238	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MYC—osteoporosis	5.33e-05	0.00022	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TGFB1—osteoporosis	5.31e-05	0.00022	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.03e-05	0.000208	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MYC—osteoporosis	4.9e-05	0.000203	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TGFB1—osteoporosis	4.89e-05	0.000202	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ENO1—osteoporosis	4.66e-05	0.000193	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PSMA5—osteoporosis	4.59e-05	0.00019	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PSMA2—osteoporosis	4.59e-05	0.00019	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—osteoporosis	4e-05	0.000166	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP19A1—osteoporosis	3.72e-05	0.000154	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—osteoporosis	3.68e-05	0.000152	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ADCY5—osteoporosis	3.04e-05	0.000126	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GPX1—osteoporosis	3.03e-05	0.000125	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MTHFR—osteoporosis	2.8e-05	0.000116	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—POMC—osteoporosis	2.24e-05	9.26e-05	CbGpPWpGaD
